Quality of Life in Sarcopenia and Frailty
| Autor: | Emmanuel Biver, Yyves Rolland, Jean-Marc Kaufman, Maria-Luisa Brandi, Vincenzo Malafarina, Andrea Laslop, Steven Boonen, Marjolein Visser, Jean-François Arnal, Jean Petermans, Olivier Bruyère, Richard O.C. Oreffo, John A. Kanis, Avan Aihie Sayer, Leocardio Rodgriguez Mañas, Jean-Yves Reginster, Bret H. Goodpaster, Ivan Bautmans, Roger A. Fielding, Cyrus Cooper, René Rizzoli, Heike A. Bischoff-Ferrari, Kieran F. Reid, Arkadi Chines, Yannis Tsouderos, Bruce H. Mitlak, Charlotte Beaudart, Sol Epstein |
|---|---|
| Přispěvatelé: | Gerontology, Frailty in Ageing, Simon, Marie Francoise, Service of Bone Diseases, Université de Genève = University of Geneva (UNIGE)-Geneva University Hospital (HUG), Department of Public Health, Epidemiology and Health Economics, Université de Liège, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Gerontology and Frailty in Ageing Research Department, Vrije Universiteit Brussel (VUB), Centre on Aging and Mobility, Universität Zürich [Zürich] = University of Zurich (UZH), Division of Geriatric Medicine, Leuven University Hospital-Center for Metabolic Bone Diseases, Department of Internal Medicine, Università degli Studi di Firenze = University of Florence (UniFI), General Endocrinology, Amgen Inc., Nutrition, Exercise Physiology and Sarcopenia Laboratory, Tufts University - Human Nutrition Research Center on Aging, Division of Endocrinology, Icahn School of Medicine at Mount Sinai [New York] (MSSM), WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield [Sheffield], Department of Medicine, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE)-Pennsylvania Commonwealth System of Higher Education (PCSHE), Department of Endocrinology, Universiteit Gent = Ghent University (UGENT), Department of Geriatrics, University Hospital of Getafe, Hospital San Juan de Dios, Bone and Joint Research Group, University of Southampton Medical School, Lilly Research Laboratories, Eli Lilly and Company, Gérontopôle, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service of Geriatrics, CHU de Liège, Pharmacology & Toxicology, Austrian Agency for Health and Food Safety (AGES), MRC Lifecourse Epidemiology Unit, University of Southampton, Développement Thérapeutique, Institut de Recherches Internationales Servier [Suresnes] (IRIS), Department of Health Sciences, Vrije Universiteit Amsterdam [Amsterdam] (VU)-VU medisch centrum, Epidemiology and Data Science, EMGO - Lifestyle, overweight and diabetes, Université de Genève (UNIGE)-Geneva University Hospital (HUG), Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Amgen Inc. USA, Universiteit Gent = Ghent University [Belgium] (UGENT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse], Vrije universiteit = Free university of Amsterdam [Amsterdam] (VU)-VU medisch centrum, University of Zurich, Rizzoli, René, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, VU University Amsterdam-VU medisch centrum, Nutrition and Health, EMGO+ - Lifestyle, Overweight and Diabetes |
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Gerontology
Aging Sarcopenia Cachexia 11221 Clinic for Geriatric Medicine Endocrinology Diabetes and Metabolism MESH: Comorbidity Comorbidity 0302 clinical medicine Endocrinology Quality of life Surveys and Questionnaires MESH: Obesity Orthopedics and Sports Medicine MESH: Aging 030212 general & internal medicine MESH: Sarcopenia Quality Of Life MESH: Aged Frailty 300 Social sciences sociology & anthropology Muscle weakness humanities 3. Good health 1310 Endocrinology 2712 Endocrinology Diabetes and Metabolism Construct (philosophy) Frail Elderly MEDLINE 030209 endocrinology & metabolism elderly Article Older population 03 medical and health sciences Age 2732 Orthopedics and Sports Medicine 360 Social problems & social services medicine Humans Asset (economics) Obesity Aged MESH: Humans business.industry MESH: Questionnaires Malnutrition MESH: Quality of Life medicine.disease MESH: Frail Elderly MESH: Cachexia ddc:618.97 business |
| Zdroj: | Vrije Universiteit Brussel Calcified Tissue International Calcified Tissue International, 2013, 93 (2), pp.101-20. ⟨10.1007/s00223-013-9758-y⟩ Calcified Tissue International, 93(2), 101-120. Springer New York Rizzoli, R, Reginster, J Y, Arnal, J F, Bautmans, I, Beaudart, C, Bischoff-Ferrari, H, Biver, E, Boonen, S, Brandi, M L, Chines, A, Cooper, C, Epstein, S, Fielding, R A, Goodpaster, B, Kanis, J A, Kaufman, J M, Laslop, A, Malafarina, V, Manas, L R, Mitlak, B H, Oreffo, R O, Petermans, J, Reid, K, Rolland, Y, Sayer, A A, Tsouderos, Y, Visser, M & Bruyere, O 2013, ' Quality of Life in Sarcopenia and Frailty ', Calcified Tissue International, vol. 93, no. 2, pp. 101-120 . https://doi.org/10.1007/s00223-013-9758-y Calcified Tissue International, Springer Verlag, 2013, 93 (2), pp.101-20. ⟨10.1007/s00223-013-9758-y⟩ Calcified Tissue International, Vol. 93, No 2 (2013) pp. 101-120 |
| ISSN: | 0171-967X 1432-0827 |
| DOI: | 10.1007/s00223-013-9758-y⟩ |
| Popis: | The reduced muscle mass and impaired muscle performance that define sarcopenia in older individuals are associated with increased risk of physical limitation and a variety of chronic diseases. They may also contribute to clinical frailty. A gradual erosion of quality of life (QoL) has been evidenced in these individuals, although much of this research has been done using generic QoL instruments, particularly the SF-36, which may not be ideal in older populations with significant comorbidities. This review and report of an expert meeting presents the current definitions of these geriatric syndromes (sarcopenia and frailty). It then briefly summarizes QoL concepts and specificities in older populations and examines the relevant domains of QoL and what is known concerning QoL decline with these conditions. It calls for a clearer definition of the construct of disability, argues that a disease-specific QoL instrument for sarcopenia/frailty would be an asset for future research, and discusses whether there are available and validated components that could be used to this end and whether the psychometric properties of these instruments are sufficiently tested. It calls also for an approach using utility weighting to provide some cost estimates and suggests that a time trade-off study could be appropriate. © 2013 Springer Science+Business Media New York. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink